[In diabetes cannabinoid antagonist kills two birds with one stone].
D063387:Cannabinoid Receptor Antagonists; D002186:Cannabinoids / Q000037:antagonists & inhibitors*; D018849:Controlled Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D024821:Metabolic Syndrome / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000077285:Rimonabant; D013997:Time Factors; D015431:Weight Loss
D063387:Cannabinoid Receptor Antagonists; D002186:Cannabinoids; D006442:Glycated Hemoglobin; D010880:Piperidines; D010919:Placebos; D011720:Pyrazoles; D000077285:Rimonabant